What is the clinical evidence from this study?

Study design: Review. Population: Cardiovascular disease. Intervention: Vascular glycocalyx.

What question did this study set out to answer?

To review updates since 2009 on the vascular glycocalyx's critical roles in mechanosensitive vasodilation, fluid exchange, and atherothrombosis development.

July 1, 2012Cardiovascular & Haematological Disorders - Drug Targets

Update on the Important New Drug Target in Cardiovascular Medicine – the Vascular Glycocalyx

View Full Paper

Ask AI

Bookmark

Key result

Vascular glycocalyx dysfunction emerges as a primary therapeutic target implicated in atherothrombosis and tissue edema.

Design

Review

Authors

ADA. J. Drake‐HollandSt George's Hospital MNMark I. M. NobleElectrophysiology

Discussion

Member takes

Implication

Hypothesis-generating for glycocalyx-targeted therapies in CVD; prospective trials needed before clinical adoption.

Key Points

To review updates since 2009 on the vascular glycocalyx's critical roles in mechanosensitive vasodilation, fluid exchange, and atherothrombosis development.
Narrative literature review synthesizing cross-disciplinary research spanning diabetes, cardiology, bioengineering, and critical care.
Assessed mechanistic pathways linking glycocalyx integrity to nitric oxide-mediated shear stress responses and microvascular permeability.
Glycocalyx degradation serves as an initial trigger for atherothrombosis by blunting shear stress-mediated, nitric oxide-dependent vasodilation in conduit arteries.
Microvascular glycocalyx breakdown under hyperglycemic conditions alters Starling fluid exchange dynamics, promoting tissue edema and microalbuminuria.
Expanding interdisciplinary research underscores the arterial glycocalyx as a primary focus for early risk prevention and pharmacological drug development.

PICO

Population

Cardiovascular disease

Exposure / Comparator

Vascular glycocalyx

The vascular glycocalyx is an increasingly recognized protective layer whose dysfunction is implicated in atherothrombosis and edema, representing a promising target for cardiovascular disease prevention.

Limitations

This update is by no means exhaustive

Cite This Study

Drake‐Holland et al. (2012) conducted a review in Cardiovascular disease. Vascular glycocalyx was evaluated. The vascular glycocalyx is an increasingly recognized multidisciplinary target in cardiovascular medicine, with its dysfunction implicated as a primary step in atherothrombosis and tissue edema.

synapsesocial.com/papers/6aa3173a8452605e3bcdeaf3 https://doi.org/10.2174/187152912801823183

View Full Paper

Ask AI

Bookmark

Update on the Important New Drug Target in Cardiovascular Medicine – the Vascular Glycocalyx

Discussion

Member takes

Implication

Key Points

PICO

Limitations

Cite This Study

Update on the Important New Drug Target in Cardiovascular Medicine – the Vascular Glycocalyx

Discussion

Member takes

Implication

Key Points

PICO

Limitations

Cite This Study

Also Consider

Also Consider